Date Filed | Type | Description |
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2022 |
4
| Beaulieu Joseph (See Remarks) has filed a Form 4 on Epizyme, Inc.
Txns:
| Paid exercise price by delivering 279,864 shares
@ $1.39, valued at
$389k
Exercised 300,000 options to buy
@ $1.39, valued at
$417k
|
|
03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2022 |
4
| Beaulieu Joseph (Corporate Controller) has filed a Form 4 on Epizyme, Inc.
Txns:
| Sold 687 shares
@ $1.37, valued at
$941.2 |
|
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/03/2020 |
4
| Beaulieu Joseph (Corporate Controller) has filed a Form 4 on Epizyme, Inc.
Txns:
| Sold 971 shares
@ $12.77, valued at
$12.4k
Sold 543 shares
@ $12.88, valued at
$7k
Granted 6,650 options to buy
@ $12.79, valued at
$85.1k
|
|
06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
03/26/2020 |
4
| Beaulieu Joseph (Corporate Controller) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 1,556 shares
@ $0 Sold 212 shares
@ $15.28, valued at
$3.2k
|
|
03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| Beaulieu Joseph (Corporate Controller) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 2,575 shares
@ $0 Granted 11,588 options to buy
@ $21.39, valued at
$247.9k
|
|
01/27/2020 |
4
| Beaulieu Joseph (Corporate Controller) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 875 shares
@ $0 Sold 330 shares
@ $24.63, valued at
$8.1k
|
|
06/14/2019 |
4
| Beaulieu Joseph (Corporate Controller) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 700 shares
@ $0 Sold 203 shares
@ $12.1, valued at
$2.5k
|
|
01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2019 |
3
| Beaulieu Joseph (Corporate Controller) has filed a Form 3 on Epizyme, Inc. |